Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06550531
Status:
RECRUITING
Last Update Posted:
None
First Post:
2022-03-31
Brief Title:
Impact of Human Papillomavirus Carriage on IVFICSI Results HPV AMP
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Impact of Human Papillomavirus Carriage on IVFICSI Results at Brest University Hospital
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HPV-AMP
Brief Summary:
The prevalence of the papilloma virus in the general population is 12 This virus is known to impair male fertility but its impact on female infertility remains uncertain This is a public health problem since there is a vaccination protocol Demonstrating the impact of the human papillomavirus on fertility would be an argument in favor of vaccination
Detailed Description:
This is a single-center prospective study in the assisted reproduction center of Brest University Hospital All new patients coming to consult will be offered participation in the study The HPV test will be updated if it is older than 12 months We will analyze stimulation results and pregnancy outcomes according to HPV status Inclusions will take place over 3 years
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None